Author(s)

Chenchen Wang, Shuangyan Yu, Xiangdong Liu And Hongyang Shi

Corresponding Author

Hongyang Shi

ABSTRACT

China is a big country of imitation, nearly ninety-seven of the drugs are made of imitation, but the quality of imitation drugs is uneven, causing widespread concern in China. The state, in order to regulate the safety of generic drugs, has steadily promoted the work since the publication of the opinions of the general office of the state Council on the quality and efficacy of generic drugs. But the products of enterprises sometimes as many as a dozen or more, this article from the perspective of pharmaceutical economics to help enterprises scientifically in many products to determine the priority of quality and efficacy consistency evaluation of products, save their capital costs, time costs, so that enterprises better deal with consistency evaluation policy, for the product to obtain a better development prospect.

KEYWORDS

Evaluation of quality consistency of generic drugs, Pharmacoeconomics, business decision making